{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:47:05Z","timestamp":1790621225152,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":256,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662463437","type":"print"},{"value":"9783662463444","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/7854_2013_256","type":"book-chapter","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T06:36:57Z","timestamp":1387435017000},"page":"101-133","source":"Crossref","is-referenced-by-count":27,"title":["Mouse Models of Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Simon P.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"key":"256_CR1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2012.10.039","volume":"238","author":"YS Abada","year":"2013","unstructured":"Abada YS, Schreiber R, Ellenbroek B (2013) Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington\u2019s disease. Behav Brain Res 238:243\u2013251","journal-title":"Behav Brain Res"},{"key":"256_CR2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/npp.2012.236","volume":"38","author":"L Agnoli","year":"2013","unstructured":"Agnoli L, Mainolfi P, Invernizzi RW, Carli M (2013) Dopamine D1-like and D2-like receptors in the dorsal striatum control different aspects of attentional performance in the five-choice serial reaction time task under a condition of increased activity of corticostriatal inputs. Neuropsychopharmacology 38:701\u2013714","journal-title":"Neuropsychopharmacology"},{"key":"256_CR3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1460-9568.2009.07042.x","volume":"31","author":"MM Albasser","year":"2010","unstructured":"Albasser MM, Poirier GL, Aggleton JP (2010) Qualitatively different modes of perirhinal-hippocampal engagement when rats explore novel vs. familiar objects as revealed by c-Fos imaging. Eur J Neurosci 31:134\u2013147","journal-title":"Eur J Neurosci"},{"key":"256_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","volume":"85","author":"GE Alexander","year":"1990","unstructured":"Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u201cprefrontal\u201d and \u201climbic\u201d functions. Prog Brain Res 85:119\u2013146","journal-title":"Prog Brain Res"},{"key":"256_CR5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"GE Alexander","year":"1986","unstructured":"Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357\u2013381","journal-title":"Annu Rev Neurosci"},{"key":"256_CR6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","volume":"37","author":"KL Allen","year":"2009","unstructured":"Allen KL, Waldvogel HJ, Glass M, Faull RL (2009) Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington\u2019s disease. J Chem Neuroanat 37:266\u2013281","journal-title":"J Chem Neuroanat"},{"key":"256_CR7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1152\/jn.01118.2005","volume":"95","author":"VM Andre","year":"2006","unstructured":"Andre VM, Cepeda C, Venegas A, Gomez Y, Levine MS (2006) Altered cortical glutamate receptor function in the R6\/2 model of Huntington\u2019s disease. J Neurophysiol 95:2108\u20132119","journal-title":"J Neurophysiol"},{"key":"256_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnsys.2011.00046","volume":"5","author":"VM Andre","year":"2011","unstructured":"Andre VM, Fisher YE, Levine MS (2011) Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington\u2019s disease. Front Syst Neurosci 5:46","journal-title":"Front Syst Neurosci"},{"key":"256_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","volume":"68","author":"MA Ariano","year":"2002","unstructured":"Ariano MA, Aronin N, DiFiglia M, Tagle DA, Sibley DR, Leavitt BR, Hayden MR, Levine MS (2002) Striatal neurochemical changes in transgenic models of Huntington\u2019s disease. J Neurosci Res 68:716\u2013729","journal-title":"J Neurosci Res"},{"key":"256_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","volume":"82","author":"EH Aylward","year":"2011","unstructured":"Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS (2011) Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82:405\u2013410","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"256_CR11","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250\u20134258","journal-title":"J Neurosci"},{"key":"256_CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44\u201379","journal-title":"Prog Neurobiol"},{"issue":"14","key":"256_CR13","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/febs.12329","volume":"280","author":"M Bari","year":"2013","unstructured":"Bari M, Battista N, Valenza M, Mastrangelo N, Malaponti M, Catanzaro G, Centonze D, Finazzi-Agro A, Cattaneo E, Maccarrone M (2013) In vitro and in vivo models of Huntington\u2019s disease show alterations in the endocannabinoid system. FEBS J 280(14):3376\u201388","journal-title":"FEBS J"},{"key":"256_CR14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000091523","volume":"21","author":"S Baudic","year":"2006","unstructured":"Baudic S, Maison P, Dolbeau G, Boisse MF, Bartolomeo P, Dalla BG, Traykov L, Bachoud-Levi AC (2006) Cognitive impairment related to apathy in early Huntington\u2019s disease. Dement Geriatr Cogn Disord 21:316\u2013321","journal-title":"Dement Geriatr Cogn Disord"},{"key":"256_CR15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s00415-006-0146-7","volume":"253","author":"CR Baumann","year":"2006","unstructured":"Baumann CR, Hersberger M, Bassetti CL (2006) Hypocretin-1 (orexin A) levels are normal in Huntington\u2019s disease. J Neurol 253:1232\u20131233","journal-title":"J Neurol"},{"key":"256_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainresbull.2011.03.013","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP (2012a) Light and electron microscopic characterization of the evolution of cellular pathology in HdhQ92 Huntington\u2019s disease knock-in mice. Brain Res Bull 88:171\u2013181","journal-title":"Brain Res Bull"},{"key":"256_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresbull.2011.07.009","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP (2012b) Light and electron microscopic characterization of the evolution of cellular pathology in the R6\/1 Huntington\u2019s disease transgenic mice. Brain Res Bull 88:104\u2013112","journal-title":"Brain Res Bull"},{"key":"256_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainresbull.2011.05.005","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP (2012c) Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington\u2019s disease transgenic mice. Brain Res Bull 88:137\u2013147","journal-title":"Brain Res Bull"},{"key":"256_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainresbull.2011.03.014","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Torres EM, Jones L, Dunnett SB, Brooks SP (2012d) Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh(CAG)150 Huntington\u2019s disease knock-in mouse. Brain Res Bull 88:189\u2013198","journal-title":"Brain Res Bull"},{"key":"256_CR20","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","volume":"14","author":"CL Benn","year":"2005","unstructured":"Benn CL, Landles C, Li H, Strand AD, Woodman B, Sathasivam K, Li SH, Ghazi-Noori S, Hockly E, Faruque SM, Cha JH, Sharpe PT, Olson JM, Li XJ, Bates GP (2005) Contribution of nuclear and extranuclear PolyQ to neurological phenotypes in mouse models of Huntington\u2019s disease. Hum Mol Genet 14:3065\u20133078","journal-title":"Hum Mol Genet"},{"key":"256_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/acps.1980.61.s280.63","volume":"280","author":"ED Bird","year":"1980","unstructured":"Bird ED, Spokes EG, Iversen LL (1980) Dopamine and noradrenaline in post-mortem brain in Huntington\u2019s disease and schizophrenic illness. Acta Psychiatr Scand Suppl 280:63\u201373","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"256_CR22","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1523\/JNEUROSCI.2820-08.2008","volume":"28","author":"GB Bissonette","year":"2008","unstructured":"Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM (2008) Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 28:11124\u201311130","journal-title":"J Neurosci"},{"key":"256_CR23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bjorklund","year":"2007","unstructured":"Bjorklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194\u2013202","journal-title":"Trends Neurosci"},{"key":"256_CR24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","volume":"14","author":"M Bjorkqvist","year":"2005","unstructured":"Bjorkqvist M, Fex M, Renstrom E, Wierup N, Petersen A, Gil J, Bacos K, Popovic N, Li JY, Sundler F, Brundin P, Mulder H (2005) The R6\/2 transgenic mouse model of Huntington\u2019s disease develops diabetes due to deficient beta-cell mass and exocytosis. Hum Mol Genet 14:565\u2013574","journal-title":"Hum Mol Genet"},{"key":"256_CR25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","volume":"18","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E (1992a) Allocortical involvement in Huntington\u2019s disease. Neuropathol Appl Neurobiol 18:539\u2013547","journal-title":"Neuropathol Appl Neurobiol"},{"key":"256_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0168-0102(92)90014-4","volume":"15","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E (1992b) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6\u201331","journal-title":"Neurosci Res"},{"key":"256_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainresbull.2010.05.005","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Janghra N, Jones L, Dunnett SB (2012a) Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL\/6\u00a0J) Huntington\u2019s disease transgenic mice. Brain Res Bull 88:113\u2013120","journal-title":"Brain Res Bull"},{"key":"256_CR28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainresbull.2010.05.004","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB (2012b) Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington\u2019s disease knock-in mice. Brain Res Bull 88:182\u2013188","journal-title":"Brain Res Bull"},{"key":"256_CR29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2010.05.003","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB (2012c) Longitudinal analysis of the behavioural phenotype in HdhQ92 Huntington\u2019s disease knock-in mice. Brain Res Bull 88:148\u2013155","journal-title":"Brain Res Bull"},{"key":"256_CR30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.brainresbull.2006.02.011","volume":"69","author":"SP Brooks","year":"2006","unstructured":"Brooks SP, Betteridge H, Trueman RC, Jones L, Dunnett SB (2006) Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington\u2019s disease. Brain Res Bull 69:452\u2013457","journal-title":"Brain Res Bull"},{"key":"256_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, Jones L, Dunnett SB (2012d) Selective cognitive impairment in the YAC128 Huntington\u2019s disease mouse. Brain Res Bull 88:121\u2013129","journal-title":"Brain Res Bull"},{"key":"256_CR32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainresbull.2011.01.010","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Janghra N, Workman VL, Bayram-Weston Z, Jones L, Dunnett SB (2012e) Longitudinal analysis of the behavioural phenotype in R6\/1 (C57BL\/6\u00a0J) Huntington\u2019s disease transgenic mice. Brain Res Bull 88:94\u2013103","journal-title":"Brain Res Bull"},{"key":"256_CR33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2011.06.008","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Jones L, Dunnett SB (2012f) Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington\u2019s disease mouse line. Brain Res Bull 88:130\u2013136","journal-title":"Brain Res Bull"},{"key":"256_CR34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1037\/0735-7044.111.5.920","volume":"111","author":"TJ Bussey","year":"1997","unstructured":"Bussey TJ, Muir JL, Everitt BJ, Robbins TW (1997) Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behav Neurosci 111:920\u2013936","journal-title":"Behav Neurosci"},{"key":"256_CR35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0028-3908(98)00199-3","volume":"38","author":"P Calabresi","year":"1999","unstructured":"Calabresi P, Centonze D, Gubellini P, Bernardi G (1999) Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology 38:323\u2013326","journal-title":"Neuropharmacology"},{"key":"256_CR36","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1523\/JNEUROSCI.12-11-04224.1992","volume":"12","author":"P Calabresi","year":"1992","unstructured":"Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G (1992a) Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J Neurosci 12:4224\u20134233","journal-title":"J Neurosci"},{"key":"256_CR37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1460-9568.1992.tb00119.x","volume":"4","author":"P Calabresi","year":"1992","unstructured":"Calabresi P, Pisani A, Mercuri NB, Bernardi G (1992b) Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur J Neurosci 4:929\u2013935","journal-title":"Eur J Neurosci"},{"key":"256_CR38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","volume":"5","author":"JW Callahan","year":"2011","unstructured":"Callahan JW, Abercrombie ED (2011) In vivo Dopamine Efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington\u2019s disease. Front Syst Neurosci 5:61","journal-title":"Front Syst Neurosci"},{"key":"256_CR39","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"256_CR40","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"256_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","volume":"66","author":"C Cepeda","year":"2001","unstructured":"Cepeda C, Ariano MA, Calvert CR, Flores-Hernandez J, Chandler SH, Leavitt BR, Hayden MR, Levine MS (2001) NMDA receptor function in mouse models of Huntington disease. J Neurosci Res 66:525\u2013539","journal-title":"J Neurosci Res"},{"key":"256_CR42","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1460-9568.2012.08141.x","volume":"36","author":"EA Chase","year":"2012","unstructured":"Chase EA, Tait DS, Brown VJ (2012) Lesions of the orbital prefrontal cortex impair the formation of attentional set in rats. Eur J Neurosci 36:2368\u20132375","journal-title":"Eur J Neurosci"},{"key":"256_CR43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2011.02.022","volume":"56","author":"Y Cheng","year":"2011","unstructured":"Cheng Y, Peng Q, Hou Z, Aggarwal M, Zhang J, Mori S, Ross CA, Duan W (2011) Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington\u2019s disease mouse model. Neuroimage 56:1027\u20131034","journal-title":"Neuroimage"},{"key":"256_CR44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nbd.2011.12.017","volume":"45","author":"V Chiodi","year":"2012","unstructured":"Chiodi V, Uchigashima M, Beggiato S, Ferrante A, Armida M, Martire A, Potenza RL, Ferraro L, Tanganelli S, Watanabe M, Domenici MR, Popoli P (2012) Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis 45:983\u2013991","journal-title":"Neurobiol Dis"},{"key":"256_CR45","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","volume":"36","author":"CT Chiu","year":"2011","unstructured":"Chiu CT, Liu G, Leeds P, Chuang DM (2011) Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease. Neuropsychopharmacology 36:2406\u20132421","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"256_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biopsycho.2006.01.005","volume":"73","author":"Y Chudasama","year":"2006","unstructured":"Chudasama Y, Robbins TW (2006) Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 73(1):19\u201338","journal-title":"Biol Psychol"},{"key":"256_CR47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nlm.2009.06.002","volume":"92","author":"A Ciamei","year":"2009","unstructured":"Ciamei A, Morton AJ (2009) Progressive imbalance in the interaction between spatial and procedural memory systems in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Learn Mem 92:417\u2013428","journal-title":"Neurobiol Learn Mem"},{"key":"256_CR48","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1523\/JNEUROSCI.1521-08.2008","volume":"28","author":"HF Clarke","year":"2008","unstructured":"Clarke HF, Robbins TW, Roberts AC (2008) Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 28:10972\u201310982","journal-title":"J Neurosci"},{"key":"256_CR49","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.1204542109","volume":"109","author":"ZR Crook","year":"2012","unstructured":"Crook ZR, Housman DE (2012) Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice. Proc Natl Acad Sci U S A 109:7487\u20137492","journal-title":"Proc Natl Acad Sci U S A"},{"key":"256_CR50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(83)90009-2","volume":"88","author":"A Cross","year":"1983","unstructured":"Cross A, Rossor M (1983) Dopamine D-1 and D-2 receptors in Huntington\u2019s disease. Eur J Pharmacol 88:223\u2013229","journal-title":"Eur J Pharmacol"},{"key":"256_CR51","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1042\/AN20100007","volume":"2","author":"DM Cummings","year":"2010","unstructured":"Cummings DM, Cepeda C, Levine MS (2010) Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington\u2019s disease. ASN Neuro 2:e00036","journal-title":"ASN Neuro"},{"key":"256_CR52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pbb.2007.12.021","volume":"90","author":"JW Dalley","year":"2008","unstructured":"Dalley JW, Mar AC, Economidou D, Robbins TW (2008) Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav 90:250\u2013260","journal-title":"Pharmacol Biochem Behav"},{"key":"256_CR53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1101\/lm.64103","volume":"10","author":"G Daoudal","year":"2003","unstructured":"Daoudal G, Debanne D (2003) Long-term plasticity of intrinsic excitability: learning rules and mechanisms. Learn Mem 10:456\u2013465","journal-title":"Learn Mem"},{"key":"256_CR54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"256_CR55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","volume":"47","author":"SM Monte de la","year":"1988","unstructured":"de la Monte SM, Vonsattel JP, Richardson EP Jr (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease. J Neuropathol Exp Neurol 47:516\u2013525","journal-title":"J Neuropathol Exp Neurol"},{"key":"256_CR56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/TCRM.S17152","volume":"7","author":"M Tommaso de","year":"2011","unstructured":"de Tommaso M, Serpino C, Sciruicchio V (2011) Management of Huntington\u2019s disease: role of tetrabenazine. Ther Clin Risk Manag 7:123\u2013129","journal-title":"Ther Clin Risk Manag"},{"key":"256_CR57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(02)02550-7","volume":"939","author":"AW Deckel","year":"2002","unstructured":"Deckel AW, Tang V, Nuttal D, Gary K, Elder R (2002) Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington\u2019s disease transgenic mice. Brain Res 939:76\u201386","journal-title":"Brain Res"},{"key":"256_CR58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease. Behav Brain Res 214:193\u2013200","journal-title":"Behav Brain Res"},{"key":"256_CR59","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"256_CR60","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0006-8993(78)91084-3","volume":"151","author":"I Divac","year":"1978","unstructured":"Divac I, Markowitsch HJ, Pritzel M (1978) Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat. Brain Res 151:523\u2013532","journal-title":"Brain Res"},{"key":"256_CR61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/h0024348","volume":"63","author":"I Divac","year":"1967","unstructured":"Divac I, Rosvold HE, Szwarcbart MK (1967) Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 63:184\u2013190","journal-title":"J Comp Physiol Psychol"},{"key":"256_CR62","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bph.12164","volume":"169","author":"J Doria","year":"2013","unstructured":"Doria J, Silva F, de Souza J, Vieira L, Carvalho T, Reis H, Pereira G, Dobransky T, Ribeiro F (2013) Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington\u2019s disease. Br J Pharmacol 169:909\u2013921","journal-title":"Br J Pharmacol"},{"key":"256_CR63","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","volume":"163","author":"MJ Dowie","year":"2009","unstructured":"Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M (2009) Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington\u2019s disease. Neuroscience 163:456\u2013465","journal-title":"Neuroscience"},{"key":"256_CR64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","volume":"170","author":"MJ Dowie","year":"2010","unstructured":"Dowie MJ, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M (2010) Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington\u2019s disease transgenic mice. Neuroscience 170:324\u2013336","journal-title":"Neuroscience"},{"key":"256_CR65","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1523\/JNEUROSCI.1486-08.2008","volume":"28","author":"B Draganski","year":"2008","unstructured":"Draganski B, Kherif F, Kloppel S, Cook PA, Alexander DC, Parker GJ, Deichmann R, Ashburner J, Frackowiak RS (2008) Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. J Neurosci 28:7143\u20137152","journal-title":"J Neurosci"},{"key":"256_CR66","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","volume":"30","author":"W Duan","year":"2008","unstructured":"Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B, Zhao M, Cadet JL, Wong J, Ross CA (2008) Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease. Neurobiol Dis 30:312\u2013322","journal-title":"Neurobiol Dis"},{"key":"256_CR67","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC (2007) Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol Psychiatry 62:1341\u20131346","journal-title":"Biol Psychiatry"},{"key":"256_CR68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1113\/jphysiol.2012.241018","volume":"591","author":"A Dvorzhak","year":"2013","unstructured":"Dvorzhak A, Semtner M, Faber DS, Grantyn R (2013) Tonic mGluR5\/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin. J Physiol 591:1145\u20131166","journal-title":"J Physiol"},{"key":"256_CR69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.expneurol.2011.08.010","volume":"232","author":"AM Farrar","year":"2011","unstructured":"Farrar AM, Callahan JW, Abercrombie ED (2011) Reduced striatal acetylcholine efflux in the R6\/2 mouse model of Huntington\u2019s disease: an examination of the role of altered inhibitory and excitatory mechanisms. Exp Neurol 232:119\u2013125","journal-title":"Exp Neurol"},{"key":"256_CR70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-4886(90)90033-O","volume":"110","author":"F Filloux","year":"1990","unstructured":"Filloux F, Wagster MV, Folstein S, Price DL, Hedreen JC, Dawson TM, Wamsley JK (1990) Nigral dopamine type-1 receptors are reduced in Huntington\u2019s disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding. Exp Neurol 110:219\u2013227","journal-title":"Exp Neurol"},{"key":"256_CR71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbr.2008.02.008","volume":"190","author":"SB Floresco","year":"2008","unstructured":"Floresco SB, Block AE, Tse MT (2008) Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal learning, using a novel, automated procedure. Behav Brain Res 190:85\u201396","journal-title":"Behav Brain Res"},{"key":"256_CR72","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S1461145711001441","volume":"15","author":"A Furr","year":"2012","unstructured":"Furr A, Lapiz-Bluhm MD, Morilak DA (2012) 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. Int J Neuropsychopharmacol 15:1295\u20131305","journal-title":"Int J Neuropsychopharmacol"},{"key":"256_CR73","first-page":"919","volume":"64","author":"T Furuyashiki","year":"2012","unstructured":"Furuyashiki T, Deguchi Y (2012) Roles of altered striatal function in major depression. Brain Nerve 64:919\u2013926","journal-title":"Brain Nerve"},{"key":"256_CR74","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/sleep\/28.12.1607","volume":"28","author":"SE Gaus","year":"2005","unstructured":"Gaus SE, Lin L, Mignot E (2005) CSF hypocretin levels are normal in Huntington\u2019s disease patients. Sleep 28:1607\u20131608","journal-title":"Sleep"},{"key":"256_CR75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nn832","volume":"5","author":"GL Gerdeman","year":"2002","unstructured":"Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446\u2013451","journal-title":"Nat Neurosci"},{"key":"256_CR76","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1460-9568.2005.04349.x","volume":"22","author":"HE Gibson","year":"2005","unstructured":"Gibson HE, Reim K, Brose N, Morton AJ, Jones S (2005) A similar impairment in CA3 mossy fibre LTP in the R6\/2 mouse model of Huntington\u2019s disease and in the complexin II knockout mouse. Eur J Neurosci 22:1701\u20131712","journal-title":"Eur J Neurosci"},{"key":"256_CR77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","volume":"6","author":"A Giralt","year":"2011","unstructured":"Giralt A, Carreton O, Lao-Peregrin C, Martin ED, Alberch J (2011a) Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6:71","journal-title":"Mol Neurodegener"},{"key":"256_CR78","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt A, Puigdellivol M, Carreton O, Paoletti P, Valero J, Parra-Damas A, Saura CA, Alberch J, Gines S (2012) Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet 21:1203\u20131216","journal-title":"Hum Mol Genet"},{"key":"256_CR79","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Martin ED, Gonzalez JR, Mila M, Cena V, Dierssen M, Canals JM, Alberch J (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseC gamma activity and glutamate receptor expression. Neuroscience 158:1234\u20131250","journal-title":"Neuroscience"},{"key":"256_CR80","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","volume":"20","author":"A Giralt","year":"2011","unstructured":"Giralt A, Saavedra A, Carreton O, Xifro X, Alberch J, Perez-Navarro E (2011b) Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington\u2019s disease. Hum Mol Genet 20:4232\u20134247","journal-title":"Hum Mol Genet"},{"key":"256_CR81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass M, Dragunow M, Faull RL (2000) The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience 97:505\u2013519","journal-title":"Neuroscience"},{"key":"256_CR82","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","volume":"56","author":"M Glass","year":"1993","unstructured":"Glass M, Faull RL, Dragunow M (1993) Loss of cannabinoid receptors in the substantia nigra in Huntington\u2019s disease. Neuroscience 56:523\u2013527","journal-title":"Neuroscience"},{"key":"256_CR83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","volume":"123","author":"M Glass","year":"2004","unstructured":"Glass M, Van Dellen A, Blakemore C, Hannan AJ, Faull RL (2004) Delayed onset of Huntington\u2019s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123:207\u2013212","journal-title":"Neuroscience"},{"key":"256_CR84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","volume":"49","author":"E Gomez-Tortosa","year":"2001","unstructured":"Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease. Ann Neurol 49:29\u201334","journal-title":"Ann Neurol"},{"key":"256_CR85","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5517-4","volume":"257","author":"AO Goodman","year":"2010","unstructured":"Goodman AO, Barker RA (2010) How vital is sleep in Huntington\u2019s disease? J Neurol 257:882\u2013897","journal-title":"J Neurol"},{"key":"256_CR86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11910-010-0163-x","volume":"11","author":"AO Goodman","year":"2011","unstructured":"Goodman AO, Rogers L, Pilsworth S, McAllister CJ, Shneerson JM, Morton AJ, Barker RA (2011) Asymptomatic sleep abnormalities are a common early feature in patients with Huntington\u2019s disease. Curr Neurol Neurosci Rep 11:211\u2013217","journal-title":"Curr Neurol Neurosci Rep"},{"key":"256_CR87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31887\/DCNS.2008.10.3\/pgorwood","volume":"10","author":"P Gorwood","year":"2008","unstructured":"Gorwood P (2008) Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci 10:291\u2013299","journal-title":"Dialogues Clin Neurosci"},{"key":"256_CR88","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770\u2013773","journal-title":"Science"},{"key":"256_CR89","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"256_CR90","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.neurobiolaging.2011.11.030","volume":"33","author":"KJ Griffioen","year":"2012","unstructured":"Griffioen KJ, Wan R, Brown TR, Okun E, Camandola S, Mughal MR, Phillips TM, Mattson MP (2012) Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington\u2019s disease. Neurobiol Aging 33:1481\u20131485","journal-title":"Neurobiol Aging"},{"key":"256_CR91","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1017\/S1092852900015650","volume":"12","author":"HJ Groenewegen","year":"2007","unstructured":"Groenewegen HJ, Trimble M (2007) The ventral striatum as an interface between the limbic and motor systems. CNS Spectr 12:887\u2013892","journal-title":"CNS Spectr"},{"key":"256_CR92","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","volume":"74","author":"P Gubellini","year":"2004","unstructured":"Gubellini P, Pisani A, Centonze D, Bernardi G, Calabresi P (2004) Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog Neurobiol 74:271\u2013300","journal-title":"Prog Neurobiol"},{"key":"256_CR93","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0028-3908(01)00021-1","volume":"40","author":"P Gubellini","year":"2001","unstructured":"Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P (2001) Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology 40:839\u2013846","journal-title":"Neuropharmacology"},{"key":"256_CR94","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.neuroimage.2011.10.072","volume":"59","author":"A Hampshire","year":"2012","unstructured":"Hampshire A, Chaudhry AM, Owen AM, Roberts AC (2012) Dissociable roles for lateral orbitofrontal cortex and lateral prefrontal cortex during preference driven reversal learning. Neuroimage 59:4102\u20134112","journal-title":"Neuroimage"},{"key":"256_CR95","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","volume":"14","author":"O Hansson","year":"2001","unstructured":"Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF, Brundin P (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J Neurosci 14:1492\u20131504","journal-title":"Eur J Neurosci"},{"key":"256_CR96","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O, Yrjanheikki JM, Buisson B, Howland D, Beaumont V, Munoz-Sanjuan I, Park LC (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7:e50717","journal-title":"PLoS ONE"},{"key":"256_CR97","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s004010051037","volume":"97","author":"H Heinsen","year":"1999","unstructured":"Heinsen H, Rub U, Bauer M, Ulmar G, Bethke B, Schuler M, Bocker F, Eisenmenger W, Gotz M, Korr H, Schmitz C (1999) Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease. Acta Neuropathol 97:613\u2013622","journal-title":"Acta Neuropathol"},{"key":"256_CR98","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","volume":"88","author":"H Heinsen","year":"1994","unstructured":"Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, Gotz M (1994) Cortical and striatal neurone number in Huntington\u2019s disease. Acta Neuropathol 88:320\u2013333","journal-title":"Acta Neuropathol"},{"key":"256_CR99","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","volume":"27","author":"MY Heng","year":"2007","unstructured":"Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL (2007) Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington\u2019s disease. J Neurosci 27:8989\u20138998","journal-title":"J Neurosci"},{"key":"256_CR100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","volume":"157","author":"MA Hickey","year":"2008","unstructured":"Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS, Chesselet MF (2008) Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington\u2019s disease mice. Neuroscience 157:280\u2013295","journal-title":"Neuroscience"},{"key":"256_CR101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","volume":"81","author":"MA Hickey","year":"2002","unstructured":"Hickey MA, Reynolds GP, Morton AJ (2002) The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington\u2019s disease. J Neurochem 81:46\u201359","journal-title":"J Neurochem"},{"key":"256_CR102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-7-12","volume":"7","author":"MA Hickey","year":"2012","unstructured":"Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS, Chesselet MF (2012) Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington\u2019s disease. Mol Neurodegener 7:12","journal-title":"Mol Neurodegener"},{"issue":"17","key":"256_CR103","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","volume":"22","author":"LS Hult","year":"2013","unstructured":"Hult LS, Nilsson N, Soylu R, Kirik D, Petersen A (2013) Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 22(17):3485\u20133497","journal-title":"Hum Mol Genet"},{"key":"256_CR104","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","volume":"48","author":"MS Hurlbert","year":"1999","unstructured":"Hurlbert MS, Zhou W, Wasmeier C, Kaddis FG, Hutton JC, Freed CR (1999) Mice transgenic for an expanded CAG repeat in the Huntington\u2019s disease gene develop diabetes. Diabetes 48:649\u2013651","journal-title":"Diabetes"},{"issue":"12","key":"256_CR105","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","volume":"22","author":"M Jiang","year":"2013","unstructured":"Jiang M, Peng Q, Liu X, Jin J, Hou Z, Zhang J, Mori S, Ross CA, Ye K, Duan W (2013) Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington\u2019s disease. Hum Mol Genet 22(12):2462\u20132470","journal-title":"Hum Mol Genet"},{"key":"256_CR106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","volume":"20","author":"K Josefsen","year":"2008","unstructured":"Josefsen K, Nielsen MD, Jorgensen KH, Bock T, Norremolle A, Sorensen SA, Naver B, Hasholt L (2008) Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington\u2019s disease. J Neuroendocrinol 20:165\u2013172","journal-title":"J Neuroendocrinol"},{"key":"256_CR107","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","volume":"29","author":"PR Joshi","year":"2009","unstructured":"Joshi PR, Wu NP, Andre VM, Cummings DM, Cepeda C, Joyce JA, Carroll JB, Leavitt BR, Hayden MR, Levine MS, Bamford NS (2009) Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci 29:2414\u20132427","journal-title":"J Neurosci"},{"key":"256_CR108","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archneur.1983.04050120041005","volume":"40","author":"RC Josiassen","year":"1983","unstructured":"Josiassen RC, Curry LM, Mancall EL (1983) Development of neuropsychological deficits in Huntington\u2019s disease. Arch Neurol 40:791\u2013796","journal-title":"Arch Neurol"},{"key":"256_CR109","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/jn.2001.85.1.117","volume":"85","author":"JN Kerr","year":"2001","unstructured":"Kerr JN, Wickens JR (2001) Dopamine D-1\/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J Neurophysiol 85:117\u2013124","journal-title":"J Neurophysiol"},{"key":"256_CR110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nlm.2004.10.003","volume":"83","author":"J Kim","year":"2005","unstructured":"Kim J, Ragozzino ME (2005) The involvement of the orbitofrontal cortex in learning under changing task contingencies. Neurobiol Learn Mem 83:125\u2013133","journal-title":"Neurobiol Learn Mem"},{"key":"256_CR111","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","volume":"30","author":"EM Kingma","year":"2008","unstructured":"Kingma EM, Van Duijn E, Timman R, Van der Mast RC, Roos RA (2008) Behavioural problems in Huntington\u2019s disease using the problem behaviours assessment. Gen Hosp Psychiatry 30:155\u2013161","journal-title":"Gen Hosp Psychiatry"},{"key":"256_CR112","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","volume":"590","author":"H Kiriazis","year":"2012","unstructured":"Kiriazis H, Jennings NL, Davern P, Lambert G, Su Y, Pang T, Du X, La Greca L, Head GA, Hannan AJ, Du XJ (2012) Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington\u2019s disease. J Physiol 590:5845\u20135860","journal-title":"J Physiol"},{"key":"256_CR113","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbr.2013.01.043","volume":"245","author":"M Klanker","year":"2013","unstructured":"Klanker M, Post G, Joosten R, Feenstra M, Denys D (2013) Deep brain stimulation in the lateral orbitofrontal cortex impairs spatial reversal learning. Behav Brain Res 245:7\u201312","journal-title":"Behav Brain Res"},{"key":"256_CR114","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","volume":"86","author":"GJ Klapstein","year":"2001","unstructured":"Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice. J Neurophysiol 86:2667\u20132677","journal-title":"J Neurophysiol"},{"key":"256_CR115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuropsychologia.2009.10.016","volume":"48","author":"S Kloppel","year":"2010","unstructured":"Kloppel S, Stonnington CM, Petrovic P, Mobbs D, Tuscher O, Craufurd D, Tabrizi SJ, Frackowiak RS (2010) Irritability in pre-clinical Huntington\u2019s disease. Neuropsychologia 48:549\u2013557","journal-title":"Neuropsychologia"},{"key":"256_CR116","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","volume":"228","author":"T Kudo","year":"2011","unstructured":"Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP, Colwell CS (2011) Dysfunctions in circadian behavior and physiology in mouse models of Huntington\u2019s disease. Exp Neurol 228:80\u201390","journal-title":"Exp Neurol"},{"key":"256_CR117","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","volume":"146","author":"VW Kung","year":"2007","unstructured":"Kung VW, Hassam R, Morton AJ, Jones S (2007) Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington\u2019s disease. Neuroscience 146:1571\u20131580","journal-title":"Neuroscience"},{"key":"256_CR118","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.410240221","volume":"24","author":"R Kurlan","year":"1988","unstructured":"Kurlan R, Goldblatt D, Zaczek R, Jeffries K, Irvine C, Coyle J, Shoulson I (1988) Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington\u2019s disease. Ann Neurol 24:282\u2013284","journal-title":"Ann Neurol"},{"key":"256_CR119","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psychres.2012.09.022","volume":"207","author":"I Labuschagne","year":"2013","unstructured":"Labuschagne I, Jones R, Callaghan J, Whitehead D, Dumas EM, Say MJ, Hart EP, Justo D, Coleman A, Dar Santos RC, Frost C, Craufurd D, Tabrizi SJ, Stout JC (2013) Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington\u2019s disease. Psychiatry Res 207:118\u2013126","journal-title":"Psychiatry Res"},{"issue":"Pt 7","key":"256_CR120","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","volume":"121","author":"AD Lawrence","year":"1998","unstructured":"Lawrence AD, Hodges JR, Rosser AE, Kershaw A, Ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998) Evidence for specific cognitive deficits in preclinical Huntington\u2019s disease. Brain 121(Pt 7):1329\u20131341","journal-title":"Brain"},{"issue":"Pt 5","key":"256_CR121","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","volume":"119","author":"AD Lawrence","year":"1996","unstructured":"Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington\u2019s disease. Brain 119(Pt 5):1633\u20131645","journal-title":"Brain"},{"key":"256_CR122","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0028-3932(99)00035-4","volume":"37","author":"AD Lawrence","year":"1999","unstructured":"Lawrence AD, Sahakian BJ, Rogers RD, Hodge JR, Robbins TW (1999) Discrimination, reversal, and shift learning in Huntington\u2019s disease: mechanisms of impaired response selection. Neuropsychologia 37:1359\u20131374","journal-title":"Neuropsychologia"},{"issue":"Pt 7","key":"256_CR123","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/brain\/123.7.1349","volume":"123","author":"AD Lawrence","year":"2000","unstructured":"Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW (2000) Visual object and visuospatial cognition in Huntington\u2019s disease: implications for information processing in corticostriatal circuits. Brain 123(Pt 7):1349\u20131364","journal-title":"Brain"},{"key":"256_CR124","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/npp.2013.1","volume":"38","author":"J Merrer Le","year":"2013","unstructured":"Le Merrer J, Rezai X, Scherrer G, Becker JA, Kieffer BL (2013) Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the delta opioid receptor. Neuropsychopharmacology 38:1050\u20131059","journal-title":"Neuropsychopharmacology"},{"key":"256_CR125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.20030","volume":"55","author":"S Lehericy","year":"2004","unstructured":"Lehericy S, Ducros M, Van de Moortele PF, Francois C, Thivard L, Poupon C, Swindale N, Ugurbil K, Kim DS (2004) Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann Neurol 55:522\u2013529","journal-title":"Ann Neurol"},{"key":"256_CR126","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.brainresbull.2012.01.012","volume":"87","author":"RP Lerner","year":"2012","unstructured":"Lerner RP, Trejo Martinez LC, Zhu C, Chesselet MF, Hickey MA (2012) Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington\u2019s disease. Brain Res Bull 87:571\u2013578","journal-title":"Brain Res Bull"},{"key":"256_CR127","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","volume":"58","author":"MS Levine","year":"1999","unstructured":"Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME, Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin S, Chesselet MF (1999) Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease. J Neurosci Res 58:515\u2013532","journal-title":"J Neurosci Res"},{"key":"256_CR128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"256_CR129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuropharm.2013.03.034","volume":"71","author":"HS Lindgren","year":"2013","unstructured":"Lindgren HS, Wickens R, Tait DS, Brown VJ, Dunnett SB (2013) Lesions of the dorsomedial striatum impair formation of attentional set in rats. Neuropharmacology 71:148\u2013153","journal-title":"Neuropharmacology"},{"key":"256_CR130","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation. J Neurosci 19:10428\u201310437","journal-title":"J Neurosci"},{"key":"256_CR131","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","volume":"33","author":"G Liot","year":"2013","unstructured":"Liot G, Zala D, Pla P, Mottet G, Piel M, Saudou F (2013) Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci 33:6298\u20136309","journal-title":"J Neurosci"},{"key":"256_CR132","doi-asserted-by":"crossref","first-page":"33719","DOI":"10.1074\/jbc.M111.236521","volume":"286","author":"M Mandal","year":"2011","unstructured":"Mandal M, Wei J, Zhong P, Cheng J, Duffney LJ, Liu W, Yuen EY, Twelvetrees AE, Li S, Li XJ, Kittler JT, Yan Z (2011) Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin. J Biol Chem 286:33719\u201333728","journal-title":"J Biol Chem"},{"key":"256_CR133","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"256_CR134","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00687718","volume":"78","author":"DM Mann","year":"1989","unstructured":"Mann DM (1989) Subcortical afferent projection systems in Huntington\u2019s chorea. Acta Neuropathol 78:551\u2013554","journal-title":"Acta Neuropathol"},{"key":"256_CR135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archneur.64.1.116","volume":"64","author":"J Marshall","year":"2007","unstructured":"Marshall J, White K, Weaver M, Flury WL, Hui S, Stout JC, Johnson SA, Beristain X, Gray J, Wojcieszek J, Foroud T (2007) Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Arch Neurol 64:116\u2013121","journal-title":"Arch Neurol"},{"key":"256_CR136","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","volume":"58","author":"B Martin","year":"2009","unstructured":"Martin B, Golden E, Carlson OD, Pistell P, Zhou J, Kim W, Frank BP, Thomas S, Chadwick WA, Greig NH, Bates GP, Sathasivam K, Bernier M, Maudsley S, Mattson MP, Egan JM (2009) Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease. Diabetes 58:318\u2013328","journal-title":"Diabetes"},{"key":"256_CR137","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1523\/JNEUROSCI.1694-10.2010","volume":"30","author":"ES Maywood","year":"2010","unstructured":"Maywood ES, Fraenkel E, McAllister CJ, Wood N, Reddy AB, Hastings MH, Morton AJ (2010) Disruption of peripheral circadian timekeeping in a mouse model of Huntington\u2019s disease and its restoration by temporally scheduled feeding. J Neurosci 30:10199\u201310204","journal-title":"J Neurosci"},{"key":"256_CR138","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nlm.2007.06.005","volume":"89","author":"MF McCool","year":"2008","unstructured":"McCool MF, Patel S, Talati R, Ragozzino ME (2008) Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching. Neurobiol Learn Mem 89:114\u2013124","journal-title":"Neurobiol Learn Mem"},{"key":"256_CR139","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2005.09.028","volume":"1063","author":"A Meier","year":"2005","unstructured":"Meier A, Mollenhauer B, Cohrs S, Rodenbeck A, Jordan W, Meller J, Otto M (2005) Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington\u2019s disease. Brain Res 1063:201\u2013203","journal-title":"Brain Res"},{"key":"256_CR140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El Khodor BF, Patry M, Suarez-Farinas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, Signer E, Tobin A, Brunner D (2009) Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol Dis 35:319\u2013336","journal-title":"Neurobiol Dis"},{"key":"256_CR141","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC, Ramboz S, Howland D (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7:e49838","journal-title":"PLoS ONE"},{"key":"256_CR142","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF (2003) Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 465:11\u201326","journal-title":"J Comp Neurol"},{"key":"256_CR143","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","volume":"42","author":"S Mievis","year":"2011","unstructured":"Mievis S, Blum D, Ledent C (2011) Worsening of Huntington disease phenotype in CB1 receptor knockout mice. Neurobiol Dis 42:524\u2013529","journal-title":"Neurobiol Dis"},{"key":"256_CR144","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","volume":"30","author":"J Miller","year":"2010","unstructured":"Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, Finkbeiner S (2010) Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington\u2019s disease molecular pathogenesis. J Neurosci 30:10541\u201310550","journal-title":"J Neurosci"},{"key":"256_CR145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","volume":"585","author":"AJ Milnerwood","year":"2007","unstructured":"Milnerwood AJ, Raymond LA (2007) Corticostriatal synaptic function in mouse models of Huntington\u2019s disease: early effects of huntingtin repeat length and protein load. J Physiol 585:817\u2013831","journal-title":"J Physiol"},{"key":"256_CR146","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","volume":"6","author":"F Mochel","year":"2011","unstructured":"Mochel F, Durant B, Durr A, Schiffmann R (2011) Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice. PLoS ONE 6:e18336","journal-title":"PLoS ONE"},{"key":"256_CR147","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","volume":"4","author":"H Moffitt","year":"2009","unstructured":"Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP (2009) Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 4:e8025","journal-title":"PLoS ONE"},{"key":"256_CR148","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","volume":"29","author":"AJ Morton","year":"2000","unstructured":"Morton AJ, Lagan MA, Skepper JN, Dunnett SB (2000) Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington\u2019s disease mutation. J Neurocytol 29:679\u2013702","journal-title":"J Neurocytol"},{"key":"256_CR149","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","volume":"25","author":"AJ Morton","year":"2005","unstructured":"Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES (2005) Disintegration of the sleep-wake cycle and circadian timing in Huntington\u2019s disease. J Neurosci 25:157\u2013163","journal-title":"J Neurosci"},{"key":"256_CR150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-4328(93)90128-D","volume":"57","author":"JL Muir","year":"1993","unstructured":"Muir JL, Page KJ, Sirinathsinghji DJ, Robbins TW, Everitt BJ (1993) Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention. Behav Brain Res 57:123\u2013131","journal-title":"Behav Brain Res"},{"key":"256_CR151","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation. J Neurosci 20:5115\u20135123","journal-title":"J Neurosci"},{"key":"256_CR152","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP Jr, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus. J Neuropathol Exp Neurol 50:729\u2013742","journal-title":"J Neuropathol Exp Neurol"},{"key":"256_CR153","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","volume":"59","author":"EJ Nestler","year":"2006","unstructured":"Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151\u20131159","journal-title":"Biol Psychiatry"},{"key":"256_CR154","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","volume":"29","author":"J Nithianantharajah","year":"2008","unstructured":"Nithianantharajah J, Barkus C, Murphy M, Hannan AJ (2008) Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington\u2019s disease transgenic mice. Neurobiol Dis 29:490\u2013504","journal-title":"Neurobiol Dis"},{"key":"256_CR155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2004.07.011","volume":"17","author":"F Norflus","year":"2004","unstructured":"Norflus F, Nanje A, Gutekunst CA, Shi G, Cohen J, Bejarano M, Fox J, Ferrante RJ, Hersch SM (2004) Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington\u2019s disease transgenic mice. Neurobiol Dis 17:319\u2013325","journal-title":"Neurobiol Dis"},{"key":"256_CR156","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/brain\/aws024","volume":"135","author":"MJ Novak","year":"2012","unstructured":"Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ (2012) Altered brain mechanisms of emotion processing in pre-manifest Huntington\u2019s disease. Brain 135:1165\u20131179","journal-title":"Brain"},{"key":"256_CR157","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2009.06501.x","volume":"112","author":"AN Ortiz","year":"2010","unstructured":"Ortiz AN, Kurth BJ, Osterhaus GL, Johnson MA (2010) Dysregulation of intracellular dopamine stores revealed in the R6\/2 mouse striatum. J Neurochem 112:755\u2013761","journal-title":"J Neurochem"},{"key":"256_CR158","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","volume":"507","author":"S Orvoen","year":"2012","unstructured":"Orvoen S, Pla P, Gardier AM, Saudou F, David DJ (2012) Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neurosci Lett 507:127\u2013132","journal-title":"Neurosci Lett"},{"key":"256_CR159","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainresbull.2008.10.007","volume":"78","author":"PN Pallier","year":"2009","unstructured":"Pallier PN, Drew CJ, Morton AJ (2009) The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington\u2019s disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res Bull 78:347\u2013355","journal-title":"Brain Res Bull"},{"key":"256_CR160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","volume":"141","author":"TY Pang","year":"2006","unstructured":"Pang TY, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ (2006) Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington\u2019s disease transgenic mice. Neuroscience 141:569\u2013584","journal-title":"Neuroscience"},{"key":"256_CR161","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry 59:57\u201363","journal-title":"Biol Psychiatry"},{"key":"256_CR162","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","volume":"82","author":"JS Paulsen","year":"2010","unstructured":"Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201\u2013207","journal-title":"Brain Res Bull"},{"key":"256_CR163","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL (2001) Neuropsychiatric aspects of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 71:310\u2013314","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"256_CR164","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","volume":"210","author":"Q Peng","year":"2008","unstructured":"Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model. Exp Neurol 210:154\u2013163","journal-title":"Exp Neurol"},{"key":"256_CR165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","volume":"14","author":"A Petersen","year":"2005","unstructured":"Petersen A, Gil J, Maat-Schieman ML, Bjorkqvist M, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P, Li JY, Roos RA, Sundler F, Mulder H, Brundin P (2005) Orexin loss in Huntington\u2019s disease. Hum Mol Genet 14:39\u201347","journal-title":"Hum Mol Genet"},{"key":"256_CR166","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/2013\/705373","volume":"26","author":"C Pidgeon","year":"2013","unstructured":"Pidgeon C, Rickards H (2013) The pathophysiology and pharmacological treatment of Huntington disease. Behav Neurol 26:245\u2013253","journal-title":"Behav Neurol"},{"key":"256_CR167","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2012.07.015","volume":"48","author":"M Pignatelli","year":"2012","unstructured":"Pignatelli M, Lebreton F, Cho YH, Leinekugel X (2012) \u201cEctopic\u201d theta oscillations and interictal activity during slow-wave state in the R6\/1 mouse model of Huntington\u2019s disease. Neurobiol Dis 48:409\u2013417","journal-title":"Neurobiol Dis"},{"key":"256_CR168","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-4328(90)90140-A","volume":"37","author":"M Pisa","year":"1990","unstructured":"Pisa M, Cyr J (1990) Regionally selective roles of the rat\u2019s striatum in modality-specific discrimination learning and forelimb reaching. Behav Brain Res 37:281\u2013292","journal-title":"Behav Brain Res"},{"key":"256_CR169","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","volume":"21","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Stanek LM, Xie Y, Franciosi S, Southwell AL, Deng Y, Butland S, Zhang W, Cheng SH, Shihabuddin LS, Hayden MR (2012) Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21:2219\u20132232","journal-title":"Hum Mol Genet"},{"key":"256_CR170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/0735-7044.116.1.105","volume":"116","author":"ME Ragozzino","year":"2002","unstructured":"Ragozzino ME, Ragozzino KE, Mizumori SJ, Kesner RP (2002) Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning. Behav Neurosci 116:105\u2013115","journal-title":"Behav Neurosci"},{"key":"256_CR171","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mcn.2013.01.005","volume":"54","author":"MI Ransome","year":"2013","unstructured":"Ransome MI, Hannan AJ (2013) Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6\/1 HD mice. Mol Cell Neurosci 54:93\u2013107","journal-title":"Mol Cell Neurosci"},{"key":"256_CR172","doi-asserted-by":"crossref","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","volume":"8","author":"I Rattray","year":"2013","unstructured":"Rattray I, Smith E, Gale R, Matsumoto K, Bates GP, Modo M (2013) Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD. PLoS ONE 8:e60012","journal-title":"PLoS ONE"},{"key":"256_CR173","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1098\/rstb.1999.0456","volume":"354","author":"PH Reddy","year":"1999","unstructured":"Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA (1999) Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington\u2019s disease. Philos Trans R Soc Lond B Biol Sci 354:1035\u20131045","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"256_CR174","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.psychres.2012.03.041","volume":"200","author":"N Reedeker","year":"2012","unstructured":"Reedeker N, Bouwens JA, Giltay EJ, Le Mair SE, Roos RA, Van der Mast RC, Van Duijn E (2012) Irritability in Huntington\u2019s disease. Psychiatry Res 200:813\u2013818","journal-title":"Psychiatry Res"},{"key":"256_CR175","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1176\/jnp.23.4.jnp434","volume":"23","author":"N Reedeker","year":"2011","unstructured":"Reedeker N, Bouwens JA, Van Duijn E, Giltay EJ, Roos RA, Van der Mast RC (2011) Incidence, course, and predictors of apathy in Huntington\u2019s disease: a two-year prospective study. J Neuropsychiatry Clin Neurosci 23:434\u2013441","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"256_CR176","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2012.03.025","volume":"47","author":"A Reiner","year":"2012","unstructured":"Reiner A, Lafferty DC, Wang HB, Del Mar N, Deng YP (2012a) The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6\/2 Huntington\u2019s disease mice. Neurobiol Dis 47:75\u201391","journal-title":"Neurobiol Dis"},{"key":"256_CR177","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2012.07.026","volume":"1473","author":"A Reiner","year":"2012","unstructured":"Reiner A, Wang HB, Del Mar N, Sakata K, Yoo W, Deng YP (2012b) BDNF may play a differential role in the protective effect of the mGluR2\/3 agonist LY379268 on striatal projection neurons in R6\/2 Huntington\u2019s disease mice. Brain Res 1473:161\u2013172","journal-title":"Brain Res"},{"key":"256_CR178","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2012.239798","volume":"591","author":"T Renoir","year":"2013","unstructured":"Renoir T, Pang TY, Mo C, Chan G, Chevarin C, Lanfumey L, Hannan AJ (2013) Differential effects of early environmental enrichment on emotionality related behaviours in Huntington\u2019s disease transgenic mice. J Physiol 591:41\u201355","journal-title":"J Physiol"},{"key":"256_CR179","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","volume":"165","author":"T Renoir","year":"2012","unstructured":"Renoir T, Pang TY, Zajac MS, Chan G, Du X, Leang L, Chevarin C, Lanfumey L, Hannan AJ (2012) Treatment of depressive-like behaviour in Huntington\u2019s disease mice by chronic sertraline and exercise. Br J Pharmacol 165:1375\u20131389","journal-title":"Br J Pharmacol"},{"key":"256_CR180","doi-asserted-by":"crossref","first-page":"e22133","DOI":"10.1371\/journal.pone.0022133","volume":"6","author":"T Renoir","year":"2011","unstructured":"Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L, Hannan AJ (2011) Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington\u2019s disease and depression. PLoS ONE 6:e22133","journal-title":"PLoS ONE"},{"key":"256_CR181","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","volume":"20","author":"RR Ribchester","year":"2004","unstructured":"Ribchester RR, Thomson D, Wood NI, Hinks T, Gillingwater TH, Wishart TM, Court FA, Morton AJ (2004) Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation. Eur J Neurosci 20:3092\u20133114","journal-title":"Eur J Neurosci"},{"key":"256_CR182","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.expneurol.2010.12.017","volume":"228","author":"AC Rising","year":"2011","unstructured":"Rising AC, Xu J, Carlson A, Napoli VV, Denovan-Wright EM, Mandel RJ (2011) Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. Exp Neurol 228:173\u2013182","journal-title":"Exp Neurol"},{"key":"256_CR183","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","volume":"16","author":"TW Robbins","year":"2012","unstructured":"Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD (2012) Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci 16:81\u201391","journal-title":"Trends Cogn Sci"},{"key":"256_CR184","first-page":"240","volume":"99","author":"L Roizin","year":"1974","unstructured":"Roizin L, Stellar S, Willson N, Whittier J, Liu JC (1974) Electron microscope and enzyme studies in cerebral biopsies of Huntington\u2019s chorea. Trans Am Neurol Assoc 99:240\u2013243","journal-title":"Trans Am Neurol Assoc"},{"key":"256_CR185","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1076\/jcen.20.6.873.1111","volume":"20","author":"MJ Roman","year":"1998","unstructured":"Roman MJ, Delis DC, Filoteo JV, Demadura TL, Paulsen J, Swerdlow NR, Swenson MR, Salmon D, Butters N, Shults C (1998) Is there a \u201csubcortical\u201d profile of attentional dysfunction? A comparison of patients with Huntington\u2019s and Parkinson\u2019s diseases on a global-local focused attention task. J Clin Exp Neuropsychol 20:873\u2013884","journal-title":"J Clin Exp Neuropsychol"},{"issue":"Suppl 3","key":"256_CR186","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/S1353-8020(08)70035-X","volume":"13","author":"RA Roos","year":"2007","unstructured":"Roos RA, Aziz NA (2007) Hypocretin-1 and secondary signs in Huntington\u2019s disease. Parkinsonism Relat Disord 13(Suppl 3):S387\u2013S390","journal-title":"Parkinsonism Relat Disord"},{"key":"256_CR187","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","volume":"65","author":"HD Rosas","year":"2005","unstructured":"Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745\u2013747","journal-title":"Neurology"},{"key":"256_CR188","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","volume":"58","author":"HD Rosas","year":"2002","unstructured":"Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, Van der KA, Jenkins BG, Dale AM, Fischl B (2002) Regional and progressive thinning of the cortical ribbon in Huntington\u2019s disease. Neurology 58:695\u2013701","journal-title":"Neurology"},{"key":"256_CR189","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1037\/h0087991","volume":"49","author":"HE Rosvold","year":"1956","unstructured":"Rosvold HE, Delgado JM (1956) The effect on delayed-alternation test performance of stimulating or destroying electrically structures within the frontal lobes of the monkey\u2019s brain. J Comp Physiol Psychol 49:365\u2013372","journal-title":"J Comp Physiol Psychol"},{"key":"256_CR190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1037\/h0038337","volume":"51","author":"HE Rosvold","year":"1958","unstructured":"Rosvold HE, Mishkin M, Szwarcbart MK (1958) Effects of subcortical lesions in monkeys on visual-discrimination and single-alternation performance. J Comp Physiol Psychol 51:437\u2013444","journal-title":"J Comp Physiol Psychol"},{"key":"256_CR191","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","volume":"23","author":"U Rub","year":"2013","unstructured":"Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, Paulson HL, Bohl J, von Gall C, Vonsattel JP, Korf HW, den Dunnen WF (2013) Degeneration of the cerebellum in Huntington\u2019s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23:165\u2013177","journal-title":"Brain Pathol"},{"key":"256_CR192","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.physbeh.2011.04.001","volume":"103","author":"DN Ruskin","year":"2011","unstructured":"Ruskin DN, Ross JL, Kawamura M Jr, Ruiz TL, Geiger JD, Masino SA (2011) A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6\/2 1\u00a0J mouse model of Huntington\u2019s disease. Physiol Behav 103:501\u2013507","journal-title":"Physiol Behav"},{"key":"256_CR193","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","volume":"12","author":"P Samadi","year":"2013","unstructured":"Samadi P, Boutet A, Rymar VV, Rawal K, Maheux J, Kvann JC, Tomaszewski M, Beaubien F, Cloutier JF, Levesque D, Sadikot AF (2013) Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington\u2019s disease. Genes Brain Behav 12:108\u2013124","journal-title":"Genes Brain Behav"},{"key":"256_CR194","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"256_CR195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/nen.0b013e318040b2c8","volume":"66","author":"G Schilling","year":"2007","unstructured":"Schilling G, Klevytska A, Tebbenkamp AT, Juenemann K, Cooper J, Gonzales V, Slunt H, Poirer M, Ross CA, Borchelt DR (2007) Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. J Neuropathol Exp Neurol 66:313\u2013320","journal-title":"J Neuropathol Exp Neurol"},{"key":"256_CR196","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s004010051038","volume":"97","author":"C Schmitz","year":"1999","unstructured":"Schmitz C, Rub U, Korr H, Heinsen H (1999) Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease. II. Optimization of a stereological estimation procedure. Acta Neuropathol 97:623\u2013628","journal-title":"Acta Neuropathol"},{"key":"256_CR197","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuropharm.2007.12.012","volume":"54","author":"SM Schotanus","year":"2008","unstructured":"Schotanus SM, Chergui K (2008) Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens. Neuropharmacology 54:837\u2013844","journal-title":"Neuropharmacology"},{"key":"256_CR198","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","volume":"102","author":"EJ Slow","year":"2005","unstructured":"Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, Deng Y, Pearson J, Vaid K, Bissada N, Wetzel R, Leavitt BR, Hayden MR (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A 102:11402\u201311407","journal-title":"Proc Natl Acad Sci U S A"},{"key":"256_CR199","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, Van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"256_CR200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1355617701711046","volume":"7","author":"J Snowden","year":"2001","unstructured":"Snowden J, Craufurd D, Griffiths H, Thompson J, Neary D (2001) Longitudinal evaluation of cognitive disorder in Huntington\u2019s disease. J Int Neuropsychol Soc 7:33\u201344","journal-title":"J Int Neuropsychol Soc"},{"key":"256_CR201","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.neuropsychologia.2008.04.018","volume":"46","author":"JS Snowden","year":"2008","unstructured":"Snowden JS, Austin NA, Sembi S, Thompson JC, Craufurd D, Neary D (2008) Emotion recognition in Huntington\u2019s disease and frontotemporal dementia. Neuropsychologia 46:2638\u20132649","journal-title":"Neuropsychologia"},{"key":"256_CR202","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archneur.55.6.801","volume":"55","author":"JS Snowden","year":"1998","unstructured":"Snowden JS, Craufurd D, Griffiths HL, Neary D (1998) Awareness of involuntary movements in Huntington disease. Arch Neurol 55:801\u2013805","journal-title":"Arch Neurol"},{"key":"256_CR203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1076\/jcen.24.2.133.998","volume":"24","author":"JS Snowden","year":"2002","unstructured":"Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington\u2019s disease. J Clin Exp Neuropsychol 24:133\u2013145","journal-title":"J Clin Exp Neuropsychol"},{"key":"256_CR204","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0028-3932(02)00221-X","volume":"41","author":"JS Snowden","year":"2003","unstructured":"Snowden JS, Gibbons ZC, Blackshaw A, Doubleday E, Thompson J, Craufurd D, Foster J, Happe F, Neary D (2003) Social cognition in frontotemporal dementia and Huntington\u2019s disease. Neuropsychologia 41:688\u2013701","journal-title":"Neuropsychologia"},{"key":"256_CR205","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","volume":"45","author":"AC Solomon","year":"2007","unstructured":"Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, Oakes D, Shoulson I, Penziner E, Paulsen JS (2007) Verbal episodic memory declines prior to diagnosis in Huntington\u2019s disease. Neuropsychologia 45:1767\u20131776","journal-title":"Neuropsychologia"},{"key":"256_CR206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11357-011-9234-4","volume":"34","author":"V Soontornniyomkij","year":"2012","unstructured":"Soontornniyomkij V, Risbrough VB, Young JW, Soontornniyomkij B, Jeste DV, Achim CL (2012) Increased hippocampal accumulation of autophagosomes predicts short-term recognition memory impairment in aged mice. Age (Dordr) 34:305\u2013316","journal-title":"Age (Dordr)"},{"key":"256_CR207","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11357-010-9145-9","volume":"32","author":"V Soontornniyomkij","year":"2010","unstructured":"Soontornniyomkij V, Risbrough VB, Young JW, Wallace CK, Soontornniyomkij B, Jeste DV, Achim CL (2010) Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brain. Age (Dordr) 32:309\u2013322","journal-title":"Age (Dordr)"},{"key":"256_CR208","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","volume":"157","author":"J Spampanato","year":"2008","unstructured":"Spampanato J, Gu X, Yang XW, Mody I (2008) Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease. Neuroscience 157:606\u2013620","journal-title":"Neuroscience"},{"key":"256_CR209","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"256_CR210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","volume":"103","author":"EG Spokes","year":"1980","unstructured":"Spokes EG (1980) Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue. Brain 103:179\u2013210","journal-title":"Brain"},{"issue":"Pt 1","key":"256_CR211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/118.1.145","volume":"118","author":"R Sprengelmeyer","year":"1995","unstructured":"Sprengelmeyer R, Lange H, Homberg V (1995) The pattern of attentional deficits in Huntington\u2019s disease. Brain 118(Pt 1):145\u2013152","journal-title":"Brain"},{"key":"256_CR212","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","volume":"82","author":"AJ Starling","year":"2005","unstructured":"Starling AJ, Andre VM, Cepeda C, de Lima M, Chandler SH, Levine MS (2005) Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington\u2019s disease. J Neurosci Res 82:377\u2013386","journal-title":"J Neurosci Res"},{"key":"256_CR213","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11910-005-0059-3","volume":"5","author":"JC Stout","year":"2005","unstructured":"Stout JC, Johnson SA (2005) Cognitive impairment and dementia in basal ganglia disorders. Curr Neurol Neurosci Rep 5:355\u2013363","journal-title":"Curr Neurol Neurosci Rep"},{"key":"256_CR214","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout JC, Jones R, Labuschagne I, O\u2019Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, Durr A, Leavitt BR, Roos RA, Langbehn DR, Tabrizi SJ, Frost C (2012) Evaluation of longitudinal 12 and 24\u00a0month cognitive outcomes in premanifest and early Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 83:687\u2013694","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"256_CR215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC (2011) Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10:31\u201342","journal-title":"Lancet Neurol"},{"issue":"7","key":"256_CR216","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637\u2013649","journal-title":"Lancet Neurol"},{"key":"256_CR217","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jagp.2012.09.005","volume":"21","author":"ET Tatro","year":"2013","unstructured":"Tatro ET, Risbrough V, Soontornniyomkij B, Young J, Shumaker-Armstrong S, Jeste DV, Achim CL (2013) Short-term recognition memory correlates with regional CNS expression of microRNA-138 in mice. Am J Geriatr Psychiatry 21:461\u2013473","journal-title":"Am J Geriatr Psychiatry"},{"key":"256_CR218","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2006.07.036","volume":"406","author":"Y Temel","year":"2006","unstructured":"Temel Y, Cao C, Vlamings R, Blokland A, Ozen H, Steinbusch HW, Michelsen KA, von Horsten S, Schmitz C, Visser-Vandewalle V (2006) Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington\u2019s disease. Neurosci Lett 406:138\u2013141","journal-title":"Neurosci Lett"},{"key":"256_CR219","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s disease collaborative research group","year":"1993","unstructured":"The Huntington\u2019s disease collaborative research group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"256_CR220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","volume":"24","author":"JC Thompson","year":"2012","unstructured":"Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS, Craufurd D (2012) Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 24:53\u201360","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"256_CR221","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropsychologia.2009.09.002","volume":"48","author":"JC Thompson","year":"2010","unstructured":"Thompson JC, Poliakoff E, Sollom AC, Howard E, Craufurd D, Snowden JS (2010) Automaticity and attention in Huntington\u2019s disease: when two hands are not better than one. Neuropsychologia 48:171\u2013178","journal-title":"Neuropsychologia"},{"key":"256_CR222","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/jnp.14.1.37","volume":"14","author":"JC Thompson","year":"2002","unstructured":"Thompson JC, Snowden JS, Craufurd D, Neary D (2002) Behavior in Huntington\u2019s disease: dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 14:37\u201343","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"256_CR223","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1460-9568.2007.05307.x","volume":"25","author":"RC Trueman","year":"2007","unstructured":"Trueman RC, Brooks SP, Jones L, Dunnett SB (2007) The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington\u2019s disease. Eur J Neurosci 25:551\u2013558","journal-title":"Eur J Neurosci"},{"key":"256_CR224","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbr.2008.01.020","volume":"189","author":"RC Trueman","year":"2008","unstructured":"Trueman RC, Brooks SP, Jones L, Dunnett SB (2008) Time course of choice reaction time deficits in the Hdh(Q92) knock-in mouse model of Huntington\u2019s disease in the operant serial implicit learning task (SILT). Behav Brain Res 189:317\u2013324","journal-title":"Behav Brain Res"},{"key":"256_CR225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2009.05.006","volume":"203","author":"RC Trueman","year":"2009","unstructured":"Trueman RC, Brooks SP, Jones L, Dunnett SB (2009) Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington\u2019s disease. Behav Brain Res 203:215\u2013222","journal-title":"Behav Brain Res"},{"key":"256_CR226","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainresbull.2011.10.019","volume":"88","author":"RC Trueman","year":"2012","unstructured":"Trueman RC, Dunnett SB, Jones L, Brooks SP (2012a) Five choice serial reaction time performance in the HdhQ92 mouse model of Huntington\u2019s disease. Brain Res Bull 88:163\u2013170","journal-title":"Brain Res Bull"},{"key":"256_CR227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainresbull.2011.03.012","volume":"88","author":"RC Trueman","year":"2012","unstructured":"Trueman RC, Jones L, Dunnett SB, Brooks SP (2012b) Early onset deficits on the delayed alternation task in the Hdh(Q92) knock-in mouse model of Huntington\u2019s disease. Brain Res Bull 88:156\u2013162","journal-title":"Brain Res Bull"},{"key":"256_CR228","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuron.2009.12.007","volume":"65","author":"AE Twelvetrees","year":"2010","unstructured":"Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, MacAskill AF, Rostaing P, Lumb MJ, Humbert S, Triller A, Saudou F, Yan Z, Kittler JT (2010) Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 65:53\u201365","journal-title":"Neuron"},{"key":"256_CR229","doi-asserted-by":"crossref","unstructured":"Vaccarino AL, Sills T, Anderson KE, Bachoud-Levi AC, Borowsky B, Craufurd D, Duff K, Giuliano J, Groves M, Guttman M, Kupchak P, Ho AK, Paulsen JS, Pedersen KF, Van Duijn E, Van Kammen DP, Evans K (2011) Assessment of depression, anxiety and apathy in prodromal and early Huntington disease. PLoS Curr 3: RRN1242","DOI":"10.1371\/currents.RRN1242"},{"key":"256_CR230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2202-9-34","volume":"9","author":"A Dellen Van","year":"2008","unstructured":"Van Dellen A, Cordery PM, Spires TL, Blakemore C, Hannan AJ (2008) Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington\u2019s disease. BMC Neurosci 9:34","journal-title":"BMC Neurosci"},{"key":"256_CR231","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4088\/JCP.v69n1116","volume":"69","author":"E Duijn Van","year":"2008","unstructured":"Van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, Van der Mast RC (2008) Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington\u2019s disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 69:1804\u20131810","journal-title":"J Clin Psychiatry"},{"key":"256_CR232","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E Duijn Van","year":"2007","unstructured":"Van Duijn E, Kingma EM, Van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19:441\u2013448","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"256_CR233","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1176\/jnp.2010.22.3.287","volume":"22","author":"E Duijn Van","year":"2010","unstructured":"Van Duijn E, Reedeker N, Giltay EJ, Roos RA, Van der Mast RC (2010) Correlates of apathy in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 22:287\u2013294","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"256_CR234","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","volume":"51","author":"K Laere Van","year":"2010","unstructured":"Van Laere K, Casteels C, Dhollander I, Goffin K, Grachev I, Bormans G, Vandenberghe W (2010) Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo. J Nucl Med 51:1413\u20131417","journal-title":"J Nucl Med"},{"key":"256_CR235","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","volume":"14","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Murphy Z, Slow EJ, Leavitt BR, Hayden MR (2005a) Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet 14:3823\u20133835","journal-title":"Hum Mol Genet"},{"key":"256_CR236","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR (2005b) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 25:4169\u20134180","journal-title":"J Neurosci"},{"key":"256_CR237","first-page":"117","volume":"36","author":"DJ Wamelen Van","year":"2013","unstructured":"Van Wamelen DJ, Aziz NA, Anink JJ, Van Steenhoven R, Angeloni D, Fraschini F, Jockers R, Roos RA, Swaab DF (2013) Suprachiasmatic nucleus neuropeptide expression in patients with Huntington\u2019s Disease. Sleep 36:117\u2013125","journal-title":"Sleep"},{"key":"256_CR238","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1468-1331.2007.01975.x","volume":"14","author":"C Verny","year":"2007","unstructured":"Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D (2007) Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 14:1344\u20131350","journal-title":"Eur J Neurol"},{"key":"256_CR239","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1471-4159.2003.01704.x","volume":"85","author":"JM Vetter","year":"2003","unstructured":"Vetter JM, Jehle T, Heinemeyer J, Franz P, Behrens PF, Jackisch R, Landwehrmeyer GB, Feuerstein TJ (2003) Mice transgenic for exon 1 of Huntington\u2019s disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J Neurochem 85:1054\u20131063","journal-title":"J Neurochem"},{"key":"256_CR240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuron.2004.07.009","volume":"43","author":"NC Voermans","year":"2004","unstructured":"Voermans NC, Petersson KM, Daudey L, Weber B, Van Spaendonck KP, Kremer HP, Fernandez G (2004) Interaction between the human hippocampus and the caudate nucleus during route recognition. Neuron 43:427\u2013435","journal-title":"Neuron"},{"key":"256_CR241","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"256_CR242","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tins.2004.06.006","volume":"27","author":"P Voorn","year":"2004","unstructured":"Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM (2004) Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27:468\u2013474","journal-title":"Trends Neurosci"},{"key":"256_CR243","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2007.06.059","volume":"1188","author":"A Wade","year":"2008","unstructured":"Wade A, Jacobs P, Morton AJ (2008) Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington\u2019s disease mutation. Brain Res 1188:61\u201368","journal-title":"Brain Res"},{"key":"256_CR244","unstructured":"Warby, SC., Graham, RK., and Hayden, M (2008) Huntington\u2019s disease. Gene Rev. http:\/\/www.ncbi.nim.nih.gov"},{"key":"256_CR245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V, Weaver M, Gusella JF, Joyner AL, MacDonald ME (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"256_CR246","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","volume":"11","author":"VC Wheeler","year":"2002","unstructured":"Wheeler VC, Gutekunst CA, Vrbanac V, Lebel LA, Schilling G, Hersch S, Friedlander RM, Gusella JF, Vonsattel JP, Borchelt DR, MacDonald ME (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11:633\u2013640","journal-title":"Hum Mol Genet"},{"key":"256_CR247","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, Li XJ, Li SH, Yi H, Vonsattel JP, Gusella JF, Hersch S, Auerbach W, Joyner AL, MacDonald ME (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9:503\u2013513","journal-title":"Hum Mol Genet"},{"key":"256_CR248","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.wnr.0000203625.09706.5d","volume":"17","author":"A White","year":"2006","unstructured":"White A, Dunnett SB (2006) Fronto-striatal disconnection disrupts operant delayed alternation performance in the rat. NeuroReport 17:435\u2013441","journal-title":"NeuroReport"},{"key":"256_CR249","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.02.006","volume":"42","author":"RH Williams","year":"2011","unstructured":"Williams RH, Morton AJ, Burdakov D (2011) Paradoxical function of orexin\/hypocretin circuits in a mouse model of Huntington\u2019s disease. Neurobiol Dis 42:438\u2013445","journal-title":"Neurobiol Dis"},{"key":"256_CR250","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/hbm.21348","volume":"33","author":"RC Wolf","year":"2012","unstructured":"Wolf RC, Gron G, Sambataro F, Vasic N, Wolf ND, Thomann PA, Saft C, Landwehrmeyer GB, Orth M (2012) Brain activation and functional connectivity in premanifest Huntington\u2019s disease during states of intrinsic and phasic alertness. Hum Brain Mapp 33:2161\u20132173","journal-title":"Hum Brain Mapp"},{"key":"256_CR251","doi-asserted-by":"crossref","first-page":"e55036","DOI":"10.1371\/journal.pone.0055036","volume":"8","author":"NI Wood","year":"2013","unstructured":"Wood NI, McAllister CJ, Cuesta M, Aungier J, Fraenkel E, Morton AJ (2013) Adaptation to experimental jet-lag in R6\/2 mice despite circadian dysrhythmia. PLoS ONE 8:e55036","journal-title":"PLoS ONE"},{"key":"256_CR252","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci 30:14708\u201314718","journal-title":"J Neurosci"},{"key":"256_CR253","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2012.02.015","volume":"46","author":"EY Yuen","year":"2012","unstructured":"Yuen EY, Wei J, Zhong P, Yan Z (2012) Disrupted GABAAR trafficking and synaptic inhibition in a mouse model of Huntington\u2019s disease. Neurobiol Dis 46:497\u2013502","journal-title":"Neurobiol Dis"},{"key":"256_CR254","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"key":"256_CR255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"C Zuccato","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M, Cattaneo E (2005) Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery. Pharmacol Res 52:133\u2013139","journal-title":"Pharmacol Res"},{"key":"256_CR256","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","volume":"18","author":"C Zuccato","year":"2008","unstructured":"Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E (2008) Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease. Brain Pathol 18:225\u2013238","journal-title":"Brain Pathol"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2013_256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T04:25:32Z","timestamp":1647750332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2013_256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783662463437","9783662463444"],"references-count":256,"URL":"https:\/\/doi.org\/10.1007\/7854_2013_256","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}